Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$194.33 - $283.97 $1.49 Million - $2.18 Million
-7,682 Reduced 83.8%
1,485 $295,000
Q2 2023

Aug 15, 2023

BUY
$223.05 - $302.68 $201,637 - $273,622
904 Added 10.94%
9,167 $2.62 Million
Q2 2023

Aug 14, 2023

SELL
$223.05 - $302.68 $303,348 - $411,644
-1,360 Reduced 14.13%
8,263 $2.36 Million
Q1 2023

May 15, 2023

BUY
$175.41 - $217.92 $404,670 - $502,741
2,307 Added 31.53%
9,623 $2.09 Million
Q4 2022

Feb 14, 2023

SELL
$204.38 - $296.82 $21,664 - $31,462
-106 Reduced 1.43%
7,316 $1.5 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $523,943 - $833,462
2,684 Added 56.65%
7,422 $2.06 Million
Q2 2022

Aug 15, 2022

BUY
$115.91 - $214.48 $549,181 - $1.02 Million
4,738 New
4,738 $906,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Zacks Investment Management Portfolio

Follow Zacks Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Zacks Investment Management with notifications on news.